Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection1
暂无分享,去创建一个
Annapurna Vyakarnam | P. Easterbrook | M. Boaz | A. Waters | S. Murad | Anele Waters | Philippa J. Easterbrook | Shahed Murad | A. Vyakarnam | Mark J. Boaz
[1] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[2] B. Palmer,et al. Discordance between Frequency of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Producing CD4+ T Cells and HIV-1-Specific Lymphoproliferation in HIV-1-Infected Subjects with Active Viral Replication , 2002, Journal of Virology.
[3] M. Altfeld,et al. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. , 2000, Current opinion in immunology.
[4] P. Rabinovitch,et al. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. , 1990, Blood.
[5] M. Mulligan,et al. A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon , 2000, Journal of Virology.
[6] D. Davies,et al. CD7 expression distinguishes subsets of CD4+ T cells with distinct functional properties and ability to support replication of HIV‐1 , 2000, European journal of immunology.
[7] B. Gazzard,et al. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. , 1999, The Journal of infectious diseases.
[8] A. Fauci,et al. Host factors in the pathogenesis of HIV disease , 1997, Immunological reviews.
[9] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[10] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[11] C. Pitcher,et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. , 2001, Journal of immunological methods.
[12] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[13] T. Kepler,et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. , 1999, AIDS research and human retroviruses.
[14] P. Frei,et al. Expansion of T cells negative for CD28 expression in hiv infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers , 1996, Medical Microbiology and Immunology.
[15] S. Hammer,et al. Host Determinants in HIV Infection and Disease: Part 1: Cellular and Humoral Immune Responses* , 2001, Annals of Internal Medicine.
[16] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[17] C. Hallahan,et al. High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] Douglas D. Richman,et al. HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function , 2000, The Journal of experimental medicine.
[19] Spyros A. Kalams,et al. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.
[20] M. Ostrowski,et al. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. , 2001, The Journal of infectious diseases.
[21] B. Walker,et al. Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection , 1999, Journal of Virology.
[22] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[23] V. Maino,et al. Enhancement of HIV type 1 antigen-specific CD4+ T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen. , 2000, AIDS research and human retroviruses.
[24] H. Thomas,et al. Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C Virus , 2002, The Journal of Immunology.
[25] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[26] P. Linsley,et al. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. , 1993, Journal of immunology.
[27] Sousa,et al. Single‐cell analysis of lymphokine imbalance in asymptomatic HIV‐1 infection: evidence for a major alteration within the CD8+ T cell subset , 1998, Clinical and experimental immunology.
[28] Z. Grossman,et al. HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.
[29] E. Rosenberg,et al. Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[30] S. Rowland-Jones,et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.
[31] M. Mulligan,et al. Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.
[32] J. Wilson,et al. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. , 2000, The Journal of infectious diseases.
[33] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[34] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[35] P. Easterbrook,et al. Long-term nonprogression in HIV infection: methodological issues and scientific priorities. Report of an international European community-National Institutes of Health Workshop, The Royal Society, London, England, November 27-29, 1995. Scientific Coordinating Committee. , 1998, AIDS Research and Human Retroviruses.
[36] M. McElrath,et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. , 1997, The New England journal of medicine.
[37] A. Rao,et al. T cell differentiation: a mechanistic view. , 2000, Current opinion in immunology.
[38] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[39] P. Easterbrook,et al. Workshop Summary: Long-Term Nonprogression in HIV Infection: Methodological Issues and Scientific Priorities Report of an International European Community–National Institutes of Health Workshop, The Royal Society, London, England, November 27–29, 1995 , 1998 .
[40] B. Walker,et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. , 1996, AIDS research and human retroviruses.
[41] R. Koup,et al. Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production. , 2001, Immunology letters.
[42] T. Ottenhoff,et al. T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation , 1986, European journal of immunology.
[43] G. Trinchieri,et al. Association between HIV‐specific T helper responses and CTL activities in pediatric AIDS , 2000, European journal of immunology.
[44] A. E. Sousa,et al. Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. , 2001, The Journal of infectious diseases.
[45] H. Ostrer,et al. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. , 1996, Journal of immunology.
[46] S. Swain,et al. CD4+ T cell effectors can become memory cells with high efficiency and without further division , 2001, Nature Immunology.
[47] D. Ho,et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.
[48] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[49] M. Jenkins,et al. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.
[50] D. Birx,et al. Comprehensive Screening for Human Immunodeficiency Virus Type 1 Subtype-Specific CD8 Cytotoxic T Lymphocytes and Definition of Degenerate Epitopes Restricted by HLA-A0207 and -CW0304 Alleles , 2002, Journal of Virology.
[51] B. Walker,et al. The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell Responses , 2000, The Journal of Immunology.
[52] M. Lederman,et al. Differential Expression of Interleukin-2 and Gamma Interferon in Human Immunodeficiency Virus Disease , 2001, Journal of Virology.